Table 1 Primary breast cancer characteristics and treatment in patients who developed RIAS
From: Radiation induced angiosarcoma of the breast: outcomes from a retrospective case series
N = 49 (%) | |
|---|---|
Median age at RIAS diagnosis (range) | 72 (51–93) |
Primary breast cancer histology | |
Infiltrating ductal carcinoma | 25 (51.0) |
Infiltrating lobular carcinoma | 3 (6.1) |
Ductal carcinoma in situ | 1 (2.0) |
Unspecified | 20 (40.8) |
Surgery for primary breast cancer | |
Wide local excision (WLE) | 18 (36.7) |
WLE and axillary lymph node dissection | 29 (59.2) |
Mastectomy | 1 (2.0) |
Mastectomy and LD flap reconstruction | 1 (2.0) |
Adjuvant therapies | |
Chemotherapy | 10 (20.4) |
Endocrine therapy | 36 (73.5) |
Trastuzumab | 3 (6.1) |
Radiation dose (Gy) (range) | |
Primary median | 50 (40–54) |
Boost median | 12.5 (10–16) |